Potential stifling effects of pharmaco-economics and regulatory policies.
作者信息
Data J L
机构信息
Upjohn Co., Kalamazoo, Michigan, USA.
出版信息
Am J Cardiol. 1998 Apr 23;81(8A):34F-35F. doi: 10.1016/s0002-9149(98)00258-6.
PMID:9604904
Abstract
摘要
相似文献
1
Potential stifling effects of pharmaco-economics and regulatory policies.
Am J Cardiol. 1998 Apr 23;81(8A):34F-35F. doi: 10.1016/s0002-9149(98)00258-6.
2
A national drug agency.一个国家药品机构。
CMAJ. 2003 Apr 15;168(8):962-3.
3
Early benefit assessment for pharmaceuticals in Germany: lessons for policymakers.德国药品的早期效益评估：给政策制定者的经验教训
Issue Brief (Commonw Fund). 2013 Oct;29:1-9.
4
The scandal of generic drug pricing: drug regulation policies need review.仿制药定价丑闻：药品监管政策需要审视。
BMJ. 2017 Feb 23;356:j947. doi: 10.1136/bmj.j947.
5
[Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].[新药的药物经济学评估：实现医疗保健预算更有效分配的潜在关键]
Ned Tijdschr Geneeskd. 2002 Jun 8;146(23):1068-71.
6
Why is the pharmaceutical industry investing increasing amounts in health economic evaluations?为什么制药行业在健康经济评估方面投入的资金越来越多？
Int J Technol Assess Health Care. 1995 Fall;11(4):750-61. doi: 10.1017/s0266462300009181.
7
European healthcare policies for controlling drug expenditure.欧洲控制药品支出的医疗政策。
Pharmacoeconomics. 2003;21(2):89-103. doi: 10.2165/00019053-200321020-00002.
8
Medicine. The intangible value of vaccination.医学。疫苗接种的无形价值。
Science. 2002 Aug 9;297(5583):937-9. doi: 10.1126/science.1075173.
9
Pharmacoeconomics comes of age?药物经济学走向成熟？
Clin Pharmacol Ther. 2008 Aug;84(2):279-80. doi: 10.1038/clpt.2008.122. Epub 2008 Jun 18.
10
Will lower drug prices jeopardize drug research? A policy fact sheet.降低药品价格会危及药物研发吗？一份政策情况说明书。
Am J Bioeth. 2004 Winter;4(1):W1-4. doi: 10.1162/152651604773067488.
Zotero 插件